Raras
Buscar doenças, sintomas, genes...
Paralisia periódica hipocalêmica
ORPHA:681CID-10 · G72.3CID-11 · 8C74.10DOENÇA RARA

A paralisia periódica hipocalêmica (hipoPP) é caracterizada por episódios de paralisia muscular que duram de algumas a 24-48 horas e estão associados à queda nos níveis de potássio no sangue.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A paralisia periódica hipocalêmica (hipoPP) é caracterizada por episódios de paralisia muscular que duram de algumas a 24-48 horas e estão associados à queda nos níveis de potássio no sangue.

Pesquisas ativas
2 ensaios
5 total registrados no ClinicalTrials.gov
Publicações científicas
821 artigos
Último publicado: 2026 Mar

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
1.0
Europe
Início
Adolescent
+ childhood
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: G72.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

💪
Músculos
11 sintomas
❤️
Coração
2 sintomas
🫁
Pulmão
2 sintomas
😀
Face
1 sintomas
🧠
Neurológico
1 sintomas

+ 12 sintomas em outras categorias

Características mais comuns

100%prev.
Hipocalemia episódica
100%prev.
Paresia hipocalêmica periódica
90%prev.
Creatina quinase levemente elevada
Muito frequente (99-80%)
90%prev.
Aumento de gotículas lipídicas intramiocelulares
Muito frequente (99-80%)
90%prev.
Morfologia anormal da fibra muscular
Muito frequente (99-80%)
90%prev.
Paralisia
Muito frequente (99-80%)
29sintomas
Muito frequente (8)
Frequente (3)
Ocasional (6)
Muito raro (5)
Sem dados (7)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 29 características clínicas mais associadas, ordenadas por frequência.

Hipocalemia episódicaEpisodic hypokalemia
Muito frequente100%
Paresia hipocalêmica periódicaPeriodic hypokalemic paresis
Muito frequente100%
Creatina quinase levemente elevadaMildly elevated creatine kinase
Muito frequente (99-80%)90%
Aumento de gotículas lipídicas intramiocelularesIncreased intramyocellular lipid droplets
Muito frequente (99-80%)90%
Morfologia anormal da fibra muscularAbnormal muscle fiber morphology
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico821PubMed
Últimos 10 anos200publicações
Pico202548 papers
Linha do tempo
2026Hoje · 2026🧪 1992Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant.

CACNA1SVoltage-dependent L-type calcium channel subunit alpha-1SDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Pore-forming, alpha-1S subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents in skeletal muscle. Calcium channels containing the alpha-1S subunit play an important role in excitation-contraction coupling in skeletal muscle via their interaction with RYR1, which triggers Ca(2+) release from the sarcoplasmic reticulum and ultimately results in muscle contraction. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group

LOCALIZAÇÃO

Cell membrane, sarcolemma, T-tubule

VIAS BIOLÓGICAS (1)
NCAM1 interactions
MECANISMO DE DOENÇA

Periodic paralysis hypokalemic 1

An autosomal dominant disorder manifested by episodic flaccid generalized muscle weakness associated with falls of serum potassium levels.

VIAS REACTOME (1)
OUTRAS DOENÇAS (8)
congenital myopathy 18hypokalemic periodic paralysis, type 1malignant hyperthermia of anesthesiaobsolete periodic paralysis with transient compartment-like syndrome
HGNC:1397UniProt:Q13698
KCNE3Potassium voltage-gated channel subfamily E member 3Candidate gene tested inModerado
FUNÇÃO

Ancillary protein that functions as a regulatory subunit of the voltage-gated potassium (Kv) channel complex composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits. KCNE3 beta subunit modulates the gating kinetics and enhances stability of the channel complex (PubMed:10646604, PubMed:11207363, PubMed:12954870). Alters the gating of the delayed rectifier Kv channel containing KCNB1 alpha subunit (PubMed:12954870). Associates with KCNC4/Kv3.4 alpha subunit

LOCALIZAÇÃO

Cell membraneCytoplasmPerikaryonCell projection, dendriteMembrane raft

VIAS BIOLÓGICAS (2)
Phase 3 - rapid repolarisationPhase 2 - plateau phase
MECANISMO DE DOENÇA

Brugada syndrome 6

A tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
18.2 TPM
Intestino delgado
12.5 TPM
Baço
11.1 TPM
Ovário
10.2 TPM
Glândula salivar
10.1 TPM
OUTRAS DOENÇAS (3)
Brugada syndrome 6Brugada syndromehypokalemic periodic paralysis
HGNC:6243UniProt:Q9Y6H6
SCN4ASodium channel protein type 4 subunit alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Pore-forming subunit of Nav1.4, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Paramyotonia congenita

An autosomal dominant channelopathy characterized by myotonia, increased by exposure to cold, intermittent flaccid paresis, not necessarily dependent on cold or myotonia, lability of serum potassium, non-progressive nature and lack of atrophy or hypertrophy of muscles. In some patients, myotonia is not increased by cold exposure (paramyotonia without cold paralysis). Patients may have a combination phenotype of PMC and HYPP.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
80.7 TPM
Adipose Visceral Omentum
29.9 TPM
Mama
21.0 TPM
Tecido adiposo
18.1 TPM
Tireoide
10.4 TPM
OUTRAS DOENÇAS (12)
potassium-aggravated myotoniacongenital myopathy 22A, classiccongenital myopathy 22B, severe fetalhyperkalemic periodic paralysis
HGNC:10591UniProt:P35499

Medicamentos aprovados (FDA)

1 medicamento encontrado nos registros da FDA americana.

💊 Dichlorphenamide (DICHLORPHENAMIDE)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

3,705 variantes patogênicas registradas no ClinVar.

🧬 SCN4A: NM_000334.4(SCN4A):c.2144C>T (p.Ala715Val) ()
🧬 SCN4A: NM_000334.4(SCN4A):c.3389C>A (p.Thr1130Lys) ()
🧬 SCN4A: NM_000334.4(SCN4A):c.3913_3914insAT (p.Leu1305fs) ()
🧬 SCN4A: NM_000334.4(SCN4A):c.2957del (p.Glu986fs) ()
🧬 SCN4A: NM_000334.4(SCN4A):c.14_18del (p.Ser5fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 2,980 variantes classificadas pelo ClinVar.

1043
1937
VUS (35.0%)
Benigna (65.0%)
VARIANTES MAIS SIGNIFICATIVAS
CACNA1S: NM_000069.3(CACNA1S):c.3929C>T (p.Pro1310Leu) [Uncertain significance]
CACNA1S: NM_000069.3(CACNA1S):c.258+3A>G [Uncertain significance]
CACNA1S: NM_000069.3(CACNA1S):c.1199A>G (p.Glu400Gly) [Uncertain significance]
CACNA1S: NM_000069.3(CACNA1S):c.953T>C (p.Ile318Thr) [Uncertain significance]
CACNA1S: NM_000069.3(CACNA1S):c.3953+3A>G [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 32
2Fase 21
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Paralisia periódica hipocalêmica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

5 ensaios clínicos encontrados, 2 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
312 papers (10 anos)
#1

Novel CACNA1S Mutation c.3491 A>C in Hypokalemic Periodic Paralysis: First Report with Functional Validation.

Journal of molecular neuroscience : MN2026 Feb 04

Hypokalemic periodic paralysis (HypoPP) is a muscle disease caused by abnormal ion channels and is characterized by recurrent skeletal muscle relaxation paralysis and hypokalemia. There are obvious triggers before disease onset, such as cold, excessive exercise, excessive consumption of sugary and high-energy foods, and overeating. The aim of this study was to elucidate the pathogenic mechanism of novel mutations in the voltage-dependent L-type calcium channel subunit alpha-1 S (CACNA1S) gene associated with HypoPP. Method: Whole-exome sequencing and American College of Medical Genetics and Genomics (ACMG) compliance analysis were performed, supplemented by serum potassium and blood biochemistry tests for bioinformatics analysis. We report a 13-year-old adolescent male patient with hypokalemic periodic paralysis, who complained of limb muscle weakness accompanied by pain for 10 h. Whole-exome sequencing revealed a mutation in the CACNA1S gene (NM_000069.3: exon27: c.3491 A>C [p. Glu1164Ala]), which was classified as an uncertain mutation. The clinical presentation and protein structure prediction of the gene mutation confirmed its pathogenic role and mechanism. The mutation caused a conformational change in the calcium ion channel. This study revealed a new mutation site in the HypoPP gene and proposed the possibility of a new pathogenesis. Moreover, obesity and low magnesium are two factors that induce HypoPP, which may increase the risk of disease.

#2

The Critical Care Phenotype of Hypokalemic Paralysis: Etiology, Outcomes, and Predictors of Respiratory Failure in a Retrospective Cohort Study.

Cureus2026 Feb

Hypokalemic periodic paralysis (HPP) presenting as acute quadriparesis is a neuromuscular emergency. While its etiology is described in general wards, its severe "critical care phenotype" in the intensive care unit (ICU) remains poorly characterized. We aimed to define this phenotype by analyzing the clinical profile, etiological spectrum, and predictors of life-threatening severity. A retrospective study was conducted of 12 patients (nine male, three female; median age: 31.5 years) admitted to a tertiary ICU (2015-2021) with acute quadriparesis and hypokalemia (median potassium: 1.75 mmol/L). We analyzed management and outcomes and compared patients requiring mechanical ventilation (MV+) with those who did not (MV-) using distribution-appropriate statistical methods to identify factors associated with respiratory failure. All patients presented with acute flaccid quadriparesis and areflexia. Five (41.7%) required invasive mechanical ventilation, defining a severe "critical care phenotype." A secondary cause was identified in eight patients (66.7%), including thyrotoxicosis (n=2), distal renal tubular acidosis (n=2), primary hyperaldosteronism, sepsis, dengue fever, and gastroenteritis. Critically, the need for mechanical ventilation was not associated with the degree of hypokalemia (MV+ 1.7 mmol/L vs. MV- 1.7 mmol/L, p=0.87) or other baseline characteristics. With potassium supplementation and targeted therapy, 11 patients (91.7%) achieved complete neurological recovery; one death occurred in a patient with sepsis. HPP in the ICU represents a distinct critical care phenotype with a high risk of respiratory failure. As the requirement for mechanical ventilation was not predicted by admission potassium levels, vigilant monitoring for respiratory muscle fatigue is warranted in all cases. Favorable outcomes are achievable with prompt correction and treatment of the underlying cause, reinforcing that HPP is a reversible ICU emergency.

#3

Hypokalemic Periodic Paralysis: A Case Report of Acute Flaccid Quadriparesis Mimicking Guillain-Barré Syndrome.

Cureus2026 Feb

Hypokalemic periodic paralysis (HPP) is an uncommon but reversible cause of acute flaccid paralysis. It can clinically resemble neurological emergencies such as Guillain-Barré syndrome (GBS), leading to potential misdiagnosis and delays in appropriate treatment. We report a 30-year-old man who presented with sudden-onset quadriparesis following an acute febrile illness with gastrointestinal symptoms characterized by fever, myalgia, arthralgia, and vomiting. Initial neurological assessment demonstrated proximal and distal weakness without sensory involvement. Laboratory tests revealed severe hypokalemia (2.2 mmol/L), mild hypomagnesemia, hypophosphatemia, and markedly elevated CRP and procalcitonin. An MRI of the brain and spine was unremarkable. Although GBS was considered, rapid improvement in muscle strength following intravenous (IV) and oral potassium supplementation supported the diagnosis of hypokalemic periodic paralysis. The patient made a full recovery with the correction of electrolytes. This case emphasizes the importance of early electrolyte evaluation in acute flaccid paralysis and highlights the need to distinguish hypokalemic paralysis from GBS, as timely potassium replacement leads to rapid and complete recovery.

#4

Unmasking malignancy-thyrotoxic hypokalemic periodic paralysis and papillary thyroid carcinoma in a young male with Graves' disease: a case report.

AME case reports2026

Thyrotoxic hypokalemic periodic paralysis (THPP) is a rare complication of hyperthyroidism, most often associated with Graves' disease. It is characterized by transient muscle weakness and hypokalemia due to an intracellular potassium shift. Although Graves' disease is also associated with an increased risk of thyroid nodularity and, in some cases, malignancy, the co-occurrence of THPP and papillary thyroid carcinoma (PTC) remains exceedingly rare. To our knowledge, this is only the second reported case documenting the simultaneous presence of all three conditions: THPP, Graves' disease, and PTC. A 26-year-old male with a known history of Graves' disease presented with acute flaccid paralysis due to THPP. This episode led to thyroid imaging, which revealed thyroid nodules and cervical lymphadenopathy. Fine-needle aspiration (FNA) was suspicious for malignancy. The patient underwent total thyroidectomy with central and left neck dissections, with final pathology confirming multifocal PTC, including a widely invasive follicular variant, and regional lymph node metastases. This case illustrates the rare triad of THPP, Graves' disease, and PTC. In this patient, an episode of THPP served as the clinical trigger that led to further thyroid evaluation and ultimately the diagnosis of an aggressive and multifocal thyroid malignancy. It emphasizes the need for thorough thyroid evaluation in patients with Graves' disease who present with THPP, as an underlying malignancy may be present. Early imaging, cytologic assessment, and surgical consultation should be considered.

#5

Steroid-induced Hypokalemic Periodic Paralysis.

Annals of African medicine2026 Feb 06

Hypokalemic periodic paralysis (HypoPP) occurs in calcium and sodium ion channelopathy, which is a rare presentation following certain triggers. This typically hereditary condition leads to episodic acute muscle weakness associated with hypokalemia, which can later present as permanent weakness. This article presents the case of a 37-year-old male who developed bilateral lower limb weakness associated with severe hypokalemia following intramuscular administration of 8 mg dexamethasone. HypoPP, though not common, should be evaluated in patients following treatment with glucocorticoids. These patients present with typical symptoms that can be managed accordingly. RésuméLa paralysie périodique hypokaliémique (PPH) survient dans le cadre d’une canalopathie calcique et sodique, une manifestation rare déclenchée par certains facteurs. Cette affection, généralement héréditaire, entraîne une faiblesse musculaire aiguë épisodique associée à une hypokaliémie, pouvant évoluer vers une faiblesse permanente. Cet article présente le cas d’un homme de 37 ans ayant développé une faiblesse bilatérale des membres inférieurs associée à une hypokaliémie sévère après l’administration intramusculaire de 8 mg de dexaméthasone. Bien que rare, la PPH doit être recherchée chez les patients traités par glucocorticoïdes. Ces patients présentent des symptômes typiques qui peuvent être pris en charge en conséquence.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC530 artigos no totalmostrando 196

2026

The Critical Care Phenotype of Hypokalemic Paralysis: Etiology, Outcomes, and Predictors of Respiratory Failure in a Retrospective Cohort Study.

Cureus
2026

Hypokalemic Periodic Paralysis: A Case Report of Acute Flaccid Quadriparesis Mimicking Guillain-Barré Syndrome.

Cureus
2026

Lithium-induced hypokalemic periodic paralysis: A rare and life-threatening complication in bipolar disorder management.

Indian journal of psychiatry
2025

Case Report: Dominant deafness-onychodystrophy syndrome and hypokalemic periodic paralysis in a single patient: a rare syndromic overlap.

Frontiers in pediatrics
2026

Unmasking malignancy-thyrotoxic hypokalemic periodic paralysis and papillary thyroid carcinoma in a young male with Graves' disease: a case report.

AME case reports
2026

Steroid-induced Hypokalemic Periodic Paralysis.

Annals of African medicine
2026

Novel CACNA1S Mutation c.3491 A>C in Hypokalemic Periodic Paralysis: First Report with Functional Validation.

Journal of molecular neuroscience : MN
2026

Silent electrolyte imbalance unmasked by paralysis: a case of hypokalemia in a middle-aged woman.

Clinical biochemistry
2026

Hypokalemic periodic paralysis type 1 with respiratory involvement: A case report and critical review of the diagnostic and therapeutic approach.

Medicina clinica
2026

Coexistence of McArdle disease and hypokalemic periodic paralysis: A case report.

Medicina clinica
2026

Efficacy of a K+ Channel Agonist, XEN1101, For Preserving Contractility in Mouse Models of Hypokalemic Periodic Paralysis.

Muscle &amp; nerve
2026

Hypokalemic Periodic Paralysis Associated With a Rare CACNA1S Variant (p.Leu1243Val): Expanding the Mutational Spectrum.

Case reports in genetics
2026

Efficacy of Retigabine in Treating Weakness in a Mouse Model of Hypokalemic Periodic Paralysis.

Muscle &amp; nerve
2025

A Pediatric Case of Hypokalemic Periodic Paralysis With Fatigue and Myalgia.

Cureus
2026

[Functional analysis of the mutant channels associated with skeletal muscle channelopathies].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
2025

A Trajectory of Thyroid Function: From Thyrotoxic Paralysis to Post-ablative Hypothyroidism.

Cureus
2025

Thyrotoxic periodic paralysis: diagnostic and management considerations.

BMJ case reports
2025

Thyrotoxic Hypokalemic Periodic Paralysis: Pathophysiological Mechanisms.

Endocrinology and metabolism (Seoul, Korea)
2026

Safety and efficacy of dichlorphenamide in patients with periodic paralysis: A systematic review and meta-analysis.

Neuromuscular disorders : NMD
2025

Exploring Etiologies of Hypokalemic Paralysis: A Case Series.

The Journal of the Association of Physicians of India
2026

Genetic Study of a Greek Family with Hypokalemic Periodic Paralysis in Four Generations.

Advances in experimental medicine and biology
2025

Hypokalemic Periodic Paralysis: A Case Report.

Cureus
2025

Unilateral Upper Extremity Paralysis Secondary to Hypokalemia and Fasting: A Case Report.

Clinical practice and cases in emergency medicine
2025

Severe Hypokalemic Paralysis Unmasking Renal Tubular Acidosis in a Patient With Sjögren's Syndrome.

Cureus
2025

Hyperthyroid Hypokalemic Periodic Paralysis in a Nepali Male; A Case Report.

Clinical case reports
2025

Genetic analysis of a family with skeletal muscle ion channelopathy and hereditary spastic paraplegia type 7 caused by SCN4A and SPG7 double mutations.

Gene
2025

Twenty-year trend of thyrotoxicosis and thyrotoxic periodic paralysis: a population-based cohort study.

European thyroid journal
2025

Redefining periodic paralysis with CACNA1S mutation in a Spanish cohort.

Neurologia
2025

Hypokalemic Periodic Paralysis in a Patient With Primary Sjögren's Syndrome and Distal Renal Tubular Acidosis: A Case Report.

Clinical medicine insights. Case reports
2025

Hypokalemic Periodic Paralysis Can Be Attributed to Exogenous Hyperthyroidism Only After Exclusion of All Primary and Secondary Causes.

The American journal of medicine
2025

Generation of three iPSC lines from patients with CACNA1S related congenital myopathy.

Stem cell research
2025

COVID-19 infection and intense physical activity in hypokalemic periodic paralysis.

Boletin medico del Hospital Infantil de Mexico
2025

Graves' disease and hypokalemic periodic paralysis: A case series.

The American journal of medicine
2025

Hypokalemic periodic paralysis associated with the atypical CACNA1S c.2690G>A (p.Arg897Lys) variant: description of 14 affected individuals from five families.

Neuromuscular disorders : NMD
2025

An Atypical Case of Sjögren's Syndrome: A Surprise Diagnosis.

Cureus
2025

Hypokalemic Periodic Paralysis with Renal Tubular Acidosis in a Patient with Autoimmune Disorder.

The Journal of the Association of Physicians of India
2025

Anesthetic Considerations for Patients With Hypokalemic Periodic Paralysis Undergoing Ambulatory Surgery: A Case Report.

A&amp;A practice
2025

Refractory ventricular fibrillation from thyrotoxic hypokalemic periodic paralysis.

The American journal of emergency medicine
2025

Unveiling Thyrotoxic Periodic Paralysis: A Rare Hyperthyroid Complication.

Cureus
2025

Exploring self-management of diet and physical activity in CACNA1S-related hypokalemic periodic paralysis: A qualitative interview study.

Journal of neuromuscular diseases
2025

Comprehensive analysis of acute flaccid paralysis with and without myelitis in Taiwanese children.

Italian journal of pediatrics
2025

Recognizing a Rare Presentation: Hypokalemic Periodic Paralysis Secondary to Amphetamine Use.

Nephrology (Carlton, Vic.)
2025

When Potassium Takes a Break: A Case Series of 3 Cases on Hypokalemic Periodic Paralysis.

Clinical case reports
2025

Feasibility of 7 T 39 K/ 23 Na Magnetic Resonance Imaging for assessing muscular ion balance in hypokalemic periodic paralysis.

Investigative radiology
2025

Atypical Electrophysiological Pattern in Hypokalemic Periodic Paralysis With CACNA1S Mutation: A Case Report.

Cureus
2025

Quetiapine-induced hypokalemic periodic paralysis in a pregnant woman: a case report.

Korean journal of family medicine
2025

Potassium-sensitive loss of muscle force in the setting of reduced inward rectifier K+ current: Implications for Andersen-Tawil syndrome.

Proceedings of the National Academy of Sciences of the United States of America
2025

A Rare Presentation of Sjögren's Syndrome With Hypokalemic Periodic Paralysis Treated Based on Renal Biopsy Findings.

Cureus
2025

STIM1 in-frame deletion of eight amino acids in a patient with moderate tubular aggregate myopathy/Stormorken syndrome.

Journal of medical genetics
2025

CACNA1S Channelopathy - A Novel Missense Variant Causing Hypokalemic Periodic Paralysis.

Indian journal of pediatrics
2024

[Thyrotoxic hypokalemic periodic paralysis in a black African man in Abidjan (Côte d'Ivoire)].

Medecine tropicale et sante internationale
2025

Insulin-induced severe thyrotoxic periodic paralysis: A case report.

World journal of clinical cases
2025

Unraveling an Uncommon Encounter: Hypokalemic Periodic Paralysis with Brugada Phenocopy Amidst Hypokalemia.

European journal of case reports in internal medicine
2025

Hypokalemic Periodic Paralysis Induced by Factitious Hyperthyroidism for Weight Reduction.

The American journal of medicine
2025

CACNA1S-associated triadopathy presenting with myalgia, muscle weakness, and asymptomatic hyperCKemia.

Therapeutic advances in neurological disorders
2025

Hypokalemic periodic paralysis, a rare yet critical condition: A case report.

Medicine international
2025

Gitelman syndrome presenting with lower limb paralysis: a case report.

Journal of medical case reports
2025

Simultaneous Cases of Familial Hypokalemic Periodic Paralysis Induced by Illicit Injection of Betamethasone.

The Journal of emergency medicine
2024

[Hypokalemia: Not Just Tubulopathies].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
2025

Mechanisms underlying the distinct K+ dependencies of periodic paralysis.

The Journal of general physiology
2025

"A Paralyzing Snack": An Endocrine Cause of Paralysis.

Acta medica (Hradec Kralove)
2025

Muscle Contractility in Hypokalemic Periodic Paralysis.

Muscle &amp; nerve
2026

Thyrotoxic Hypokalemic Periodic Paralysis Induced by High-Dose Insulin in an Adolescent Male with Type 1 Diabetes Mellitus.

Hormone research in paediatrics
2024

Thyrotoxic Periodic Paralysis With Graves' Disease: A Case Report.

Cureus
2024

Quantitative Muscle MRI to Monitor Disease Progression in Hypokalemic Period Paralysis.

Neurology. Genetics
2024

Bartter Syndrome With Recurrent Hypokalemic Periodic Paralysis: A Case Report.

Cureus
2024

Hypokalemic periodic paralysis presenting as cardiac arrest.

BMJ case reports
2024

A Case Report on Hypokalemic Periodic Paralysis.

Cureus
2024

Thyrotoxic Periodic Paralysis: A Rare Cause of Quadriparesis in a Young and Seemingly Healthy Patient.

Medicina (Kaunas, Lithuania)
2024

Periodic Paralysis: A Case Series with a Literature Review.

Case reports in neurology
2024

A Novel CLCN1 Gene Mutation Associated with Hypokalemic Periodic Paralysis in a Pregnant Woman.

The Israel Medical Association journal : IMAJ
2024

A novel case of Vibrio bacteremia in an immune-competent patient.

Indian journal of medical microbiology
2024

Familial hypokalemic periodic paralysis: a case induced by concurrent hyperthyroidism.

BMC nephrology
2025

Genetic background of neonatal hypokalemia.

Pediatric nephrology (Berlin, Germany)
2024

Pediatric neuromuscular channelopathies.

Handbook of clinical neurology
2024

Coincident Thyrotoxic Hypokalemic Periodic Paralysis and Cardiomyopathy.

Journal of investigative medicine high impact case reports
2024

Primary Sjogren's syndrome presenting as hypokalaemic periodic paralysis and acute pancreatitis.

BMJ case reports
2024

A single-center retrospective study on the clinical features of thyrotoxic periodic paralysis.

PloS one
2024

[A case report of a MODY 10 family presenting as hypokalemic periodic paralysis].

Zhonghua nei ke za zhi
2024

Anaesthetic management of a parturient with hypokalaemic periodic paralysis for caesarean section: A case report and review of the literature.

Anaesthesia and intensive care
2024

Quality of life in hypokalemic periodic paralysis - a survey.

Neuromuscular disorders : NMD
2024

Case report: thyrotoxic periodic paralysis, an unusual cause of hypokalemia.

Acta clinica Belgica
2024

Early-Onset Autosomal Dominant Myopathy with Vacuolated Fibers and Tubular Aggregates but No Periodic Paralysis, in a Patient with the c.1583G>A (p.R528H) mutation in the CACNA1S Gene.

Journal of neuromuscular diseases
2024

Diagnosis, management and outcomes of primary hypokalemic periodic paralysis during pregnancy.

Obstetric medicine
2024

Case 13-2024: A 27-Year-Old Man with Leg Weakness.

The New England journal of medicine
2024

Genetic analysis of 37 cases with primary periodic paralysis in Chinese patients.

Orphanet journal of rare diseases
2024

Hypokalemic Periodic Paralysis: A Rare Case of a Descending Flaccid Paralysis.

Cureus
2024

A Rare Case of Hypokalemic Periodic Paralysis With Acute Urinary Retention: Diagnosis and Management.

Cureus
2024

Physiotherapy Strategies in Hypokalemic Periodic Paralysis: A Case Report.

Cureus
2024

Hypokalemic Periodic Paralysis Type 2 Due to SCN4A Val1105Met Mutation: A Case Study.

Cureus
2024

Gestational Transient Thyrotoxicosis Can Lead to Hypokalemic Periodic Paralysis.

Chonnam medical journal
2024

Crossover randomized controlled trial of bumetanide to rescue an attack of exercise induced hand weakness in hypokalaemic periodic paralysis.

Neuromuscular disorders : NMD
2025

Intravenous methylprednisolone-induced hypokalaemic periodic paralysis in a thyrotoxic patient: a case report and literature review.

Orbit (Amsterdam, Netherlands)
2023

Thyrotoxic periodic paralysis presenting with quadriparesis and hyperreflexia.

BMJ case reports
2023

Newly Diagnosed Hypokalemic Periodic Paralysis Triggered by COVID-19.

Cureus
2023

Hypokalemic periodic paralysis in a teenage boy after an intense period of exercise: A rare case report.

Clinical case reports
2023

A Thyrotoxic Periodic Paralysis Case Study: From Weakness to Wellness.

Cureus
2023

Thyrotoxic Periodic Paralysis as an Ongoing Diagnostic Challenge: A Case Report and Literature Review.

Cureus
2024

Prevalence and risk factors of low vitamin D levels in children and adolescents with familial hypokalemic periodic paralysis.

European journal of pediatrics
2023

Case report: A novel CACNA1S mutation associated with hypokalemic periodic paralysis.

Frontiers in neurology
2023

A novel CACNA1S gene variant in a child with hypokalemic periodic paralysis: a case report and literature review.

BMC pediatrics
2023

Hypokalemic periodic paralysis: a 3-year follow-up study.

Journal of neurology
2024

Kidney manifestations of pediatric Sjögren's syndrome.

Pediatric nephrology (Berlin, Germany)
2023

An Instance of Hypokalemic Periodic Paralysis in Adolescent Brothers: A Case Report.

Cureus
2023

Clinical features and recovery pattern of secondary hypokalaemic paralysis.

Journal of neurology
2023

Muscle MRI in periodic paralysis shows myopathy is common and correlates with intramuscular fat accumulation.

Muscle &amp; nerve
2024

Potential Benefit of Channel Activators in Loss-of-Function Primary Potassium Channelopathies Causing Heredoataxia.

Cerebellum (London, England)
2023

Hypokalemic paralysis due to renal tubular acidosis: uncommon initial manifestation of primary Sjögren´s syndrome.

ARP rheumatology
2023

Hypokalemic periodic paralysis as the first sign of thyrotoxicosis- a rare case report from Somalia.

Thyroid research
2023

Panic Attack, Severe Hypophosphatemia and Rhabdomyolysis in the Setting of a Motor Functional Neurological Disorder.

Brain sciences
2023

How is Guillain-Barre syndrome associated with COVID-19 infection differentiated from hypokalemic periodic paralysis? a case report.

Annals of medicine and surgery (2012)
2023

A Case of Sudden-Onset Flaccid Paralysis In a Previously Healthy Person.

Cureus
2023

An Interesting Case of Weakness and Atrial Tachycardia in the Emergency Department: Thinking Beyond Hearts and Minds.

Cureus
2023

Optical measurement of gating pore currents in hypokalemic periodic paralysis model cells.

Disease models &amp; mechanisms
2023

Thyrotoxic periodic paralysis: a rare cause of periodic paralysis - a case report.

Annals of medicine and surgery (2012)
2023

Hypokalemic periodic paralysis presenting as asymmetric focal flaccid paralysis: A case report and literature review.

Heliyon
2022

Thyrotoxic hypokalemic periodic paralysis and COVID-19 infection.

Journal of family medicine and primary care
2023

Steroid-induced hypokalemic periodic paralysis: a case report and literature review.

BMC nephrology
2023

Sinus arrest in familial hypokalemic periodic paralysis caused by SCN4A mutation: a case report.

European review for medical and pharmacological sciences
2023

A Case of Thyrotoxic Periodic Paralysis: "I Can't Move!".

Cureus
2023

Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencing.

Neuromuscular disorders : NMD
2023

Thyrotoxic periodic paralysis associated with lactic metabolic acidosis: Case report of an African man and review of literature.

Annales d'endocrinologie
2023

Recurrent hypokalemic paralysis in hypothyroidism.

The American journal of the medical sciences
2022

Case report: SCN4A p.R1135H gene variant in combination with thyrotoxicosis causing hypokalemic periodic paralysis.

Frontiers in neurology
2023

Retigabine suppresses loss of force in mouse models of hypokalaemic periodic paralysis.

Brain : a journal of neurology
2022

Thyrotoxic Periodic Paralysis: The Peril of Potassium Replacement.

Cureus
2023

Pathophysiologic approach in genetic hypokalemia: An update.

Annales d'endocrinologie
2022

Subclinical hyperthyroidism presenting with hypokalemic periodic paralysis in the emergency department.

Oxford medical case reports
2023

Atypical presentation of hypokalemic periodic paralysis: A case report.

Muscle &amp; nerve
2022

A Successful Obstetric Outcome in a Woman With Familial Hypokalemic Periodic Paralysis: Challenges in Management.

Cureus
2022

Cardiac arrhythmias in primary hypokalemic periodic paralysis: Case report and literature review.

HeartRhythm case reports
2022

Arterial blood gas analysis aids early differential diagnosis and treatment of primary and secondary hypokalaemic periodic paralysis.

JPMA. The Journal of the Pakistan Medical Association
2023

Secondary hypokalemic periodic paralysis in Crohn disease: Two case reports.

European journal of neurology
2022

Hypokalemic Periodic Paralysis Secondary to Medullary Sponge Kidney Complicated With Renal Tubular Acidosis.

Cureus
2022

Hypokalemic Periodic Paralysis Exacerbated by Carbohydrate Load: A Case Report.

Cureus
2022

Novel compound heterozygous mutation of SLC12A3 in Gitelman syndrome co-existent with hyperthyroidism: A case report and literature review.

World journal of clinical cases
2022

Thyrotoxic periodic paralysis in a patient with Graves' disease: A case report.

Annals of medicine and surgery (2012)
2022

Periodic paralysis due to cumulative effects of rare variants in SCN4A with small functional alterations.

Muscle &amp; nerve
2022

Late-Onset Hypokalemic Periodic Paralysis in an Adult Female With Type 2 Renal Tubular Acidosis: A Case Report.

Cureus
2022

COVID-19 Infection-Related Thyrotoxic Hypokalemic Periodic Paralysis.

Case reports in endocrinology
2022

Acute flaccid paralysis in Indonesian adult due to suspected familial hypokalemia paralysis: A rare case.

Annals of medicine and surgery (2012)
2022

A dangerous food binge: a case report of hypokalemic periodic paralysis and review of current literature.

Italian journal of pediatrics
2022

Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target.

Psychopharmacology bulletin
2022

Voltage-dependent Ca2+ release is impaired in hypokalemic periodic paralysis caused by CaV1.1-R528H but not by NaV1.4-R669H.

American journal of physiology. Cell physiology
2022

Childbirth with epidural analgesia in a pregnant woman with hypokalemic periodic paralysis.

Revista espanola de anestesiologia y reanimacion
2022

Case report: Hyperthyroid hypokalemic periodic paralysis.

Annals of medicine and surgery (2012)
2022

Hypokalemic Periodic Paralysis: An Atypical Presentation of Non-autoimmune Hypothyroidism With Distal Renal Tubular Acidosis.

Cureus
2022

Renal tubular acidosis and nephrogenic diabetes insipidus caused by Sjögren's syndrome with hypokalemic periodic paralysis as the first symptom: A case report.

Revue neurologique
2022

Stroke-mimicking unilateral hypokalemic paralysis and literature review.

The American journal of emergency medicine
2022

Short-Communication: Variable Expression of Clinical Symptoms and an Unexpected Finding of Vacuolar Myopathy Related to a Pathogenic Variant in the CACNA1S Gene in a Previous Case Report.

Cureus
2022

[Muscle weakness in the extremities in a man with Graves' disease].

Ugeskrift for laeger
2021

Hypokalemic Periodic Paralysis in Pregnancy: A Case Report.

Nigerian medical journal : journal of the Nigeria Medical Association
2021

Atypical Fracture of Femur in Association with Familial Hypokalemic Periodic Paralysis: A Case Report.

Journal of orthopaedic case reports
2022

Excitability properties of mouse and human skeletal muscle fibres compared by muscle velocity recovery cycles.

Neuromuscular disorders : NMD
2022

When cardiology meets endocrinology: sustained atrial flutter associated with thyrotoxic periodic paralysis.

Oxford medical case reports
2022

Hypokalemic periodic paralysis and renal tubular acidosis in a patient with hypothyroid and autoimmune disease.

Annals of medicine and surgery (2012)
2022

Electrocardiographic Manifestation in Thyrotoxic Periodic Paralysis.

Cureus
2022

Thyrotoxic periodic paralysis (TPP): assessment in the emergency department.

BMJ case reports
2022

Development of high-affinity nanobodies specific for NaV1.4 and NaV1.5 voltage-gated sodium channel isoforms.

The Journal of biological chemistry
2022

The role of nephrologists in management of hypokalemic periodic paralysis: a case report.

Journal of medical case reports
2022

Refractory familial hypokalaemic periodic paralysis leading to cardiovascular compromise.

BMJ case reports
2021

Glucocorticoid-Induced Hypokalemic Periodic Paralysis after Short-Term Use of Tenofovir with Hypophosphatemia: A Case Report.

Medicina (Kaunas, Lithuania)
2022

Novel CACNA1S mutation in hypokalaemic periodic paralysis.

BMJ case reports
2021

Thyrotoxic periodic paralysis presenting as a broad complex tachycardia.

British journal of hospital medicine (London, England : 2005)
2021

Thyrotoxic periodic paralysis in two sexagenarian men: A case report.

Medicine
2021

Hyperemesis Gravidarum Presenting as Severe Hypokalemic Periodic Paralysis and Type II Respiratory Failure: A Different Form of Thyroid Storm?

Cureus
2022

The long exercise test as a functional marker of periodic paralysis.

Muscle &amp; nerve
2021

A case of multifocal papillary carcinoma and thyrotoxicosis: Hypokalemic periodic paralysis.

JAAPA : official journal of the American Academy of Physician Assistants
2021

Vacuolar Myopathy Associated to CACNA1S Mutation as a Rare Cause of Late-Onset Limb-Girdle Myopathy: A Case Report.

Cureus
2021

Case Report: A Novel CACNA1S Mutation Associated With Hypokalemic Periodic Paralysis in a Chinese Family.

Frontiers in genetics
2022

Distal renal tubular acidosis and hypokalaemic periodic paralysis during pregnancy.

Journal of nephrology
2021

Osteoporosis Complicating Renal Tubular Acidosis in Association With Sjogren's Syndrome.

Cureus
2022

Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes.

Neurogenetics
2021

Genetic Screening of Patients with Thyrotoxic Hypokalemic Periodic Paralysis: An Experience from a Tertiary Care Hospital in the Northeast of Brazil.

Endocrine, metabolic &amp; immune disorders drug targets
2021

Hyperemesis Gravidarum With Paraparesis and Tetany.

Cureus
2021

Gating pore currents occur in CaV1.1 domain III mutants associated with HypoPP.

The Journal of general physiology
2021

Confirming Genetic Abnormalities of Hypokalemic Periodic Paralysis Using Next-Generation Sequencing: A Case Report and Literature Review.

Electrolyte &amp; blood pressure : E &amp; BP
2021

Reversible Severe Rhabdomyolysis Associated with Thyrotoxic Hypokalemic Periodic Paralysis.

Case reports in neurology
2021

Hypokalemic Periodic Paralysis Precipitated by Thyrotoxicosis and Renal Tubular Acidosis.

Case reports in endocrinology
2021

A Case of Hypokalemic Periodic Paralysis in a Young Athlete.

Cureus
2021

Thyrotoxic Periodic Paralysis in a Young Hispanic Male With Newly Diagnosed Grave's Disease.

Cureus
2021

Hypokalaemic periodic paralysis secondary to subclinical hyperthyroidism: an uncommon cause of acute muscle paralysis.

BMJ case reports
2021

Autophagy is affected in patients with hypokalemic periodic paralysis: an involvement in vacuolar myopathy?

Acta neuropathologica communications
2021

Peripheral nerve dysfunction in a patient with thyrotoxic periodic paralysis: Evidence from an axonal prolonged exercise test.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2021

Thyrotoxic Hypokalemic Periodic Paralysis: A Success Story of a Diagnostic Challenge.

Cureus
2021

Clinical and genetic spectrum of a Chinese cohort with SCN4A gene mutations.

Neuromuscular disorders : NMD
2021

Field Diagnosis and Treatment of Hypokalemic Periodic Paralysis by a Helicopter Emergency Medical Services Team.

Air medical journal
2021

Thyrotoxic Periodic Paralysis with Thyroid Storm as the First Presentation of Graves' disease; a Case Report.

Archives of academic emergency medicine
2021

A 29-year-old Bodybuilder with Liothyronine-induced Thyrotoxic Hypokalaemic Periodic Paralysis.

European journal of case reports in internal medicine
2021

Paroxysmal narrow complex tachycardia secondary to hypokalaemic periodic paralysis.

British journal of hospital medicine (London, England : 2005)
2021

Hypokalemic Periodic Paralysis Masquerading as a Compressive Neuraxial Lesion Following Lumbar Epidural Placement in a Parturient: A Case Report.

A&amp;A practice
2021

[Thyrotropin-secreting pituitary adenomas presenting as hypokalemic periodic paralysis and abnormal elevation of androgen: a case report].

Zhonghua nei ke za zhi
2021

Exercise test for patients with new-onset paroxysmal kinesigenic dyskinesia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021

The Role of Nutrition and Physical Activity as Trigger Factors of Paralytic Attacks in Primary Periodic Paralysis.

Journal of neuromuscular diseases
2021

Terahertz Wave Enhances Permeability of the Voltage-Gated Calcium Channel.

Journal of the American Chemical Society
2021

Anaesthesia challenges of a parturient with paramyotonia congenita and terminal filum lipoma presenting for labour and caesarean section under epidural anaesthesia - a case report.

BMC anesthesiology
Ver todos os 530 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Paralisia periódica hipocalêmica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Paralisia periódica hipocalêmica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Novel CACNA1S Mutation c.3491&#xa0;A&gt;C in Hypokalemic Periodic Paralysis: First Report with Functional Validation.
    Journal of molecular neuroscience : MN· 2026· PMID 41634283mais citado
  2. The Critical Care Phenotype of Hypokalemic Paralysis: Etiology, Outcomes, and Predictors of Respiratory Failure in a Retrospective Cohort Study.
    Cureus· 2026· PMID 41869263mais citado
  3. Hypokalemic Periodic Paralysis: A Case Report of Acute Flaccid Quadriparesis Mimicking Guillain-Barr&#xe9; Syndrome.
    Cureus· 2026· PMID 41869153mais citado
  4. Unmasking malignancy-thyrotoxic hypokalemic periodic paralysis and papillary thyroid carcinoma in a young male with Graves' disease: a case report.
    AME case reports· 2026· PMID 41676194mais citado
  5. Steroid-induced Hypokalemic Periodic Paralysis.
    Annals of African medicine· 2026· PMID 41656493mais citado
  6. Permanent weakness and myopathy in hypokalemic periodic paralysis.
    Acta Myol· 2026· PMID 41954147recente
  7. Lifestyle and dietary measures in Periodic Paralyses.
    Acta Myol· 2026· PMID 41954145recente
  8. Hypokalemic periodic paralysis associated with atypical CACNA1S in pregnancy: New challenge for a rare syndrome.
    Int J Gynaecol Obstet· 2026· PMID 41944566recente
  9. Unmasking Hypokalemic Periodic Paralysis: The Rare Role of Levothyroxine in a Pakistani Woman.
    AACE Endocrinol Diabetes· 2026· PMID 41938294recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:681(Orphanet)
  2. MONDO:0008223(MONDO)
  3. GARD:6729(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q622828(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Paralisia periódica hipocalêmica
Compêndio · Raras BR

Paralisia periódica hipocalêmica

ORPHA:681 · MONDO:0008223
Prevalência
1-9 / 100 000
Herança
Autosomal dominant
CID-10
G72.3 · Paralisia periódica
CID-11
Ensaios
2 ativos
Início
Adolescent, Childhood
Prevalência
1.0 (Europe)
MedGen
UMLS
C0238358
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades